查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1333924

前列腺素市场：现状分析与预测（2022-2030）

Prostaglandin Market: Current Analysis and Forecast (2022-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 152 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于前列腺素药物的研究不断增加，预计前列腺素市场在预测期内将以 8% 的复合年增长率增长。例如，在南里奥格兰德联邦大学，比较PSLT和局部应用前列腺素类降压滴眼液治疗高眼压或青光眼患者的效果，以达到降低眼内压的目的。使用计算机视野测量和光疗法进行。

按类型划分，市场分为合成和天然。根据分析，合成材料领域在 2021 年获得了主要份额。合成前列腺素通常用于治疗多种疾病，包括溃疡、青光眼和勃起功能障碍。合成前列腺素可以大量生产，这是其在前列腺素领域占有较大份额的重要因素。

市场根据类别分为人类和兽医产品。预计在预测期内，前列腺素市场的兽医细分市场将以更高的复合年增长率增长。越来越多地采用宠物和牲畜以及其中慢性病的患病率不断上升是推动兽医行业增长的主要原因。

市场按应用细分为心血管、妇产科、眼科等。根据我们的分析，心血管领域在 2021 年获得了主要份额。心脏病患病率的增加是心血管疾病在前列腺素市场中占有较大份额的主要原因。例如，根据世界卫生组织 (WHO) 的统计，心血管疾病 (CVD) 是全球头号死亡原因，每年估计夺去 1,790 万人的生命。

为了更好地了解该行业的市场采用情况，市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、意大利、西班牙、欧洲其他地区）、亚太地区（中国、日本、印度、韩国、澳大利亚和亚太地区的其他国家），其他国家则根据其在世界上的存在情况进行分析。2021年前列腺素市场中，北美地区占据压倒性份额。这主要是由于美国等主要经济体的存在，其中大量老年人口的存在是该地区前列腺素市场增长的关键因素。例如，根据社区生活管理局的数据，2019 年美国 65 岁及以上人口有 5410 万人，其中女性 3000 万，男性 2410 万。

目录

第一章 市场介绍

  • 市场定义
  • 主要目的
  • 利益相关者
  • 限制

第二章 研究方法或假设

  • 调查过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第五章新型冠状病毒感染（COVID-19）对全球前列腺素市场的影响

第六章全球前列腺素市场收入，2020-2028

第 7 章按类型划分的市场洞察

  • 合成
  • 自然

第八章按类别划分的市场洞察

  • 人类
  • 兽医

第 9 章 按应用划分的市场洞察

  • 心血管
  • 妇科手术
  • 眼科
  • 其他

第10章按地区划分的市场洞察

  • 北美前列腺素市场
    • 美国
    • 加拿大
    • 其他北美
  • 欧洲前列腺素市场
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太前列腺素市场
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 亚太地区其他国家
  • 其他地区前列腺素市场

第十一章前列腺素市场动态

  • 市场驱动力
  • 市场挑战
  • 影响分析

第十二章前列腺素市场机会

第十三章前列腺素市场趋势

第十四章需求侧和供给侧分析

  • 需求侧分析
  • 供给侧分析

第十五章价值链分析

第十六章价格分析

第十七章战略洞察

第18章 竞争场景

  • 竞争格局
    • 波特五力分析

第十九章公司简介

  • Sanofi
  • Cayman Chemical
  • YONSUNG Fine Chemicals Co.
  • Johnson Matthey
  • Chirogate International Inc.
  • Everlight Chemical Industrial Co.
  • Merck KGaA
  • Zhejiang Ausun Pharmaceutical Co., Ltd.
  • AspenBio
  • Pfizer Inc.

第二十章 免责声明

简介目录
Product Code: UMHE212095

Prostaglandins are hormone-like substances that play a crucial role in several physiological processes such as inflammation, pain, and blood clotting. These compounds are produced naturally by the body and are also available in synthetic forms for therapeutic use. The increasing prevalence of chronic diseases such as arthritis, cancer, and cardiovascular diseases, which require the use of prostaglandin-based medications is the important factor driving the growth of the prostaglandin market. For instance, as per the Rheumatoid Arthritis Network, in 2021, around 350 million people are living with arthritis globally.

Prostaglandin Market is expected to grow at a strong CAGR of 8% during the forecast period owing to increasing research efforts on the prostaglandin drug. For instance, the Federal University of Rio Grande do Sul conducted to compare the efficacy of topical application of PSLT and prostaglandin-like antihypertensive eye drops in the treatment of patients with ocular hypertension or glaucoma to reduce intraocular pressure and to reduce intraocular pressure using computerized perimetry and light therapy.

Based on type, the market is segmented into synthetic and natural. As per our analysis, the synthetic segment acquired a major share in 2021. Synthetic prostaglandins are typically used in the treatment of a variety of conditions, including ulcers, glaucoma, and erectile dysfunction. Synthetic prostaglandin can be produced in large quantities which is an important factor for the large share of the prostaglandin segment.

Based on the category, the market is segmented into human and veterinary. The veterinary segment is expected to grow with a higher CAGR in the prostaglandin market during the forecast period. The rising adoption of pets and livestock animals, along with the increasing prevalence of chronic disease among them is the major reason driving the growth of the veterinary segment.

Based on application, the market is segmented into cardiovascular, gynecological and obstetrical, ophthalmologic, and others. As per our analysis, the cardiovascular segment acquired a major share in 2021. The increasing prevalence of cardiac diseases is the main reason for the large share of cardiovascular diseases in the prostaglandin market. For instance, as per the World Health Organization (WHO), Cardiovascular disease (CVD) is the leading cause of death worldwide, claiming an estimated 17.9 million lives each year.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North American region held the dominant share of the prostaglandin market in 2021. This is mainly due to the presence of major economies such as the U.S., along with the presence of a large geriatric population in the region are the important factors for the market growth of the prostaglandin market in the region. For instance, as per the Administration for Community Living, In 2019, there were 54.1 million people aged 65 and over, including 30 million women and 24.1 million men in the U.S.

Some of the major players operating in the market include: Sanofi.; Cayman Chemical; YONSUNG Fine Chemicals Co.; Johnson Matthey; Chirogate International Inc.; Everlight Chemical Industrial Co.; Merck KGaA; Zhejiang Ausun Pharmaceutical Co., Ltd.; AspenBio; and Pfizer Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Prostaglandin Market
  • 2.2. Research Methodology of the Prostaglandin Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL PROSTAGLANDIN MARKET COVID-19 IMPACT

6 GLOBAL PROSTAGLANDIN MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Synthetic
  • 7.2. Natural

8 MARKET INSIGHTS BY CATEGORY

  • 8.1. Human
  • 8.2. Veterinary

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Cardiovascular
  • 9.2. Gynecological and Obstetrical
  • 9.3. Ophthalmologic
  • 9.4. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Prostaglandin Market
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Prostaglandin Market
    • 10.2.1. Germany
    • 10.2.2. UK
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific Prostaglandin Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of APAC
  • 10.4. Rest of the World Prostaglandin Market

11 PROSTAGLANDIN MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 PROSTAGLANDIN MARKET OPPORTUNITIES

13 PROSTAGLANDIN MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1. Competitive Landscape
    • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

  • 19.1. Sanofi
  • 19.2. Cayman Chemical
  • 19.3. YONSUNG Fine Chemicals Co.
  • 19.4. Johnson Matthey
  • 19.5. Chirogate International Inc.
  • 19.6. Everlight Chemical Industrial Co.
  • 19.7. Merck KGaA
  • 19.8. Zhejiang Ausun Pharmaceutical Co., Ltd.
  • 19.9. AspenBio
  • 19.10. Pfizer Inc.

20 DISCLAIMER